Copley-Merriman K. Value for money: assessing the value of a pharmaceutical product. Presented at the University of Michigan Translational Pharmacology Course 621; October 6, 2016.
Nelson LM, Copley-Merriman K, Norquist J, Powers J. PRO evidence dossier: evidence to support labeling and promotional claims for FDA-regulated medicine products. Poster presented at the International Society for Quality of Life Research Workshop #3; October 2009.
Offen W, Chuang-Stein C, Dmitrienko A, Copley-Merriman K. Multiple co-primary endpoints: medical and statistical solutions: a report from the multiple endpoints expert team of the PhRMA. Drug Inf J. 2007;4:31-46.
Salerno DF, Copley-Merriman C, Taylor TN, Shinogle J, Schulz RM. A review of functional status measures for workers with upper extremity disorders. Occup Environ Med. 2002 Oct;59(10):664-70.